Replies to post #92524 on Avid Bioservices Inc (CDMO)

[cjgaddy]

But, that 2nd-Line "MOS Ctl-Arm < 6 mos" statement was really a sort of addendum to the 5-21-12 PR's real purpose: to report top-line ORR & PFS (Bavi3mg doubled ORR% to 17.9% and improved PFS by 50% to 4.5mos http://tinyurl.com/73aeyxj ). In the Front-Line case, topline ORR & PFS have already been reported (3-9-12 http://tinyurl.com/7m9r6ya ).